Tekla Life Sciences Investors (HQL) — Net Asset Quality Index
Tekla Life Sciences Investors (HQL) has a Net Asset Quality Index of 99.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $515.38 Million minus total liabilities of $1.73 Million yields net assets of $513.66 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Tekla Life Sciences Investors to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tekla Life Sciences Investors Net Asset Quality Index Over Time (1996–2025)
This chart shows how Tekla Life Sciences Investors's Net Asset Quality Index has evolved across 28 annual periods from 1996 to 2025. As of September 2025, the index stands at 99.7%, representing net assets of $513.66 Million against total assets of $515.38 Million USD. Explore Tekla Life Sciences Investors cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Tekla Life Sciences Investors (1996–2025)
The table below presents the year-by-year Net Asset Quality Index for Tekla Life Sciences Investors from 1996 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Tekla Life Sciences Investors (HQL) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.7% | $513.66 Million | $515.38 Million | $1.73 Million | ▼ -0.1 pp |
| 2024 | 99.8% | $459.69 Million | $460.58 Million | $888.61K | ▼ 0.0 pp |
| 2023 | 99.8% | $401.93 Million | $402.60 Million | $666.96K | ▲ +3.9 pp |
| 2022 | 95.9% | $397.90 Million | $414.73 Million | $16.82 Million | ▼ -2.0 pp |
| 2021 | 98.0% | $523.44 Million | $534.19 Million | $10.75 Million | ▼ -1.9 pp |
| 2020 | 99.9% | $483.57 Million | $484.17 Million | $595.18K | ▲ +0.6 pp |
| 2019 | 99.3% | $384.16 Million | $386.98 Million | $2.82 Million | ▼ -0.1 pp |
| 2018 | 99.4% | $475.49 Million | $478.47 Million | $2.98 Million | ▼ -0.2 pp |
| 2017 | 99.6% | $466.35 Million | $468.33 Million | $1.98 Million | ▲ +0.2 pp |
| 2016 | 99.4% | $414.97 Million | $417.63 Million | $2.66 Million | ▲ +0.4 pp |
| 2015 | 98.9% | $462.84 Million | $467.85 Million | $5.01 Million | ▼ -0.9 pp |
| 2014 | 99.8% | $444.09 Million | $444.84 Million | $754.55K | ▲ +0.0 pp |
| 2013 | 99.8% | $302.29 Million | $302.82 Million | $530.12K | ▲ +0.0 pp |
| 2012 | 99.8% | $227.08 Million | $227.48 Million | $404.67K | ▲ +0.4 pp |
| 2011 | 99.4% | $170.60 Million | $171.60 Million | $1.00 Million | ▲ +1.5 pp |
| 2010 | 97.9% | $251.40 Million | $256.80 Million | $5.40 Million | ▲ +4.1 pp |
| 2009 | 93.8% | $248.60 Million | $265.10 Million | $16.50 Million | ▼ -5.1 pp |
| 2008 | 98.9% | $277.80 Million | $281.00 Million | $3.20 Million | ▼ -0.8 pp |
| 2007 | 99.6% | $308.00 Million | $309.10 Million | $1.10 Million | ▲ +0.6 pp |
| 2006 | 99.0% | $268.10 Million | $270.80 Million | $2.70 Million | ▼ -0.6 pp |
| 2005 | 99.6% | $229.30 Million | $230.30 Million | $1.00 Million | ▲ +0.2 pp |
| 2004 | 99.3% | $191.80 Million | $193.10 Million | $1.30 Million | ▲ +0.7 pp |
| 2003 | 98.7% | $190.40 Million | $193.00 Million | $2.60 Million | ▼ -1.2 pp |
| 2002 | 99.8% | $157.60 Million | $157.90 Million | $300.00K | ▲ +0.2 pp |
| 2001 | 99.6% | $215.10 Million | $215.90 Million | $800.00K | ▲ +1.0 pp |
| 1998 | 98.6% | $100.00 Million | $101.40 Million | $1.40 Million | ▼ -1.2 pp |
| 1997 | 99.8% | $132.00 Million | $132.20 Million | $200.00K | ▲ +0.3 pp |
| 1996 | 99.5% | $123.10 Million | $123.70 Million | $600.00K | — |